sun pharma Archives - Equitypandit

Sun Pharma Signs Global Licensing Deal for Philogen’s Anti-Cancer Immunotherapy, Shares Down 1%

Dhruva KulkarniOctober 1, 2024October 1, 2024

by Dhruva KulkarniOctober 1, 2024October 1, 202412598

Shares of Sun Pharmaceutical Industries Ltd. fell by 1% after reaching a day’s high of Rs 1,934.75 on 1st October. This followed the company’s announcement...

BUSINESS

LIC Offloads 2% Stake in Sun Pharmaceutical

Ali WaghbakriwalaSeptember 15, 2023September 15, 2023

by Ali WaghbakriwalaSeptember 15, 2023September 15, 202303667

LIC (Life Insurance Corporation of India), on 14 September, had divested a 2.011% stake in Sun Pharmaceutical Industries Ltd, taking its stake in the company...

BUSINESS

Sun Pharma Completes Acquisition of Concert Pharmaceuticals

NileshMarch 7, 2023March 7, 2023

by NileshMarch 7, 2023March 7, 202301882

On Monday, pharmaceutical giant Sun Pharma said it had completed its acquisition of US-based Concert Pharmaceuticals. In January, the Mumbai-based company signed a deal to...

STOCK MARKET

Sensex Falls Over 150 Points in Early Trade, Nifty at 18,650

NileshDecember 5, 2022December 5, 2022

by NileshDecember 5, 2022December 5, 202201648

Benchmark stock indexes opened lower on Monday amid mixed global cues. The BSE Sensex traded 183 points or 0.29% lower at 62,685. In contrast, the...

MARKETS

RIL Among Mutual Fund’s 10 Most Desired Stocks During Earnings Season

NileshNovember 14, 2022November 14, 2022

by NileshNovember 14, 2022November 14, 202202143

Mutual funds ramped up bets on the Mukesh Ambani-led company in October despite an unexpected drop in Reliance Industries (RIL) second-quarter profit. Two other top...

BUSINESS

Sun Pharma Signs License Agreement with SPARC to Commercialise Drug in US Market

NileshNovember 9, 2022November 9, 2022

by NileshNovember 9, 2022November 9, 202201297

Pharmaceutical giant Sun Pharma said on Wednesday it had signed a licensing deal with Sun Pharma Advanced Research Company to commercialise a drug for neonatal...

STOCK MARKET

Sensex Revisits 61,000 Mark on Optimistic Global Cues

NileshNovember 8, 2022November 8, 2022

by NileshNovember 8, 2022November 8, 202201606

The Sensex rose more than 230 points on Monday, reclaiming the 61,000-point mark, driven by strong buying in banking, autos and metals shares amid a...

MARKETS

Sun Pharma Soars 7% in Two Days, Now Trading at 5-Month High

NileshSeptember 29, 2022September 29, 2022

by NileshSeptember 29, 2022September 29, 202202072

Shares of Sun Pharmaceutical Industries rose 4% on the BSE to hit a five-month high of Rs 954.25 in intraday trade on Thursday. Shares of...

STOCK MARKET

Rupee Slips to 79.80 Against USD as Sensex, Nifty50 Dip Sharply on Negative Global Hints

NileshSeptember 16, 2022

by NileshSeptember 16, 202202034

India’s stock benchmark fell on Friday, tracking pessimism in global markets, as data from the world’s largest economy offered little reason to ease the Fed’s...

STOCK MARKET

Sensex Gains for Second Day, Boosted by Reliance, ICICI Bank and ITC Stocks

NileshSeptember 5, 2022

by NileshSeptember 5, 202201674

India’s stock market benchmark had a strong start to the week, led by gains in financials, oil and gas, IT and metals, but losses in...

Download Unicorn Signals App

EquityPandit

Tag : sun pharma

Sun Pharma Signs Global Licensing Deal for Philogen’s Anti-Cancer Immunotherapy, Shares Down 1%

LIC Offloads 2% Stake in Sun Pharmaceutical

Sun Pharma Completes Acquisition of Concert Pharmaceuticals

Sensex Falls Over 150 Points in Early Trade, Nifty at 18,650

RIL Among Mutual Fund’s 10 Most Desired Stocks During Earnings Season

Sun Pharma Signs License Agreement with SPARC to Commercialise Drug in US Market

Sensex Revisits 61,000 Mark on Optimistic Global Cues

Sun Pharma Soars 7% in Two Days, Now Trading at 5-Month High

Rupee Slips to 79.80 Against USD as Sensex, Nifty50 Dip Sharply on Negative Global Hints

Sensex Gains for Second Day, Boosted by Reliance, ICICI Bank and ITC Stocks

EquityPandit